Agora, Inc. - ADS (NQ:API)
3.700
+0.020
(+0.54%)
Streaming Delayed Price
Updated: 2:50 PM EDT, Apr 10, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 116,020 |
| Open | 3.680 |
| Bid (Size) | 3.690 (1,500) |
| Ask (Size) | 3.700 (200) |
| Prev. Close | 3.680 |
| Today's Range | 3.680 - 3.750 |
| 52wk Range | 2.525 - 5.149 |
| Shares Outstanding | 462,477,527 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Agora Bets on AI Tutors, Talking Toys For Revival ↗
May 30, 2025
12 Information Technology Stocks Moving In Thursday's Intraday Session ↗
November 20, 2025
Agora API Q3 2025 Earnings Call Transcript ↗
November 19, 2025
Agora, Inc. Reports Third Quarter 2025 Financial Results
November 19, 2025
Earnings Scheduled For November 19, 2025 ↗
November 19, 2025
Agora, Inc. Reports Second Quarter 2025 Financial Results
August 18, 2025
Earnings Scheduled For August 18, 2025 ↗
August 18, 2025
Earnings Scheduled For May 27, 2025 ↗
May 27, 2025
Frequently Asked Questions
Is Agora, Inc. - ADS publicly traded?
Yes, Agora, Inc. - ADS is publicly traded.
What exchange does Agora, Inc. - ADS trade on?
Agora, Inc. - ADS trades on the Nasdaq Stock Market
What is the ticker symbol for Agora, Inc. - ADS?
The ticker symbol for Agora, Inc. - ADS is API on the Nasdaq Stock Market
What is the current price of Agora, Inc. - ADS?
The current price of Agora, Inc. - ADS is 3.700
When was Agora, Inc. - ADS last traded?
The last trade of Agora, Inc. - ADS was at 04/10/26 02:50 PM ET
What is the market capitalization of Agora, Inc. - ADS?
The market capitalization of Agora, Inc. - ADS is 1.71B
How many shares of Agora, Inc. - ADS are outstanding?
Agora, Inc. - ADS has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.